According to the binding potential of our results and the PPARG antagonistic effects of Tanshinone IIA in other study [44], Tanshinone IIA can probably acted as a PPARG antagonist in the inhibition of prostate cancer growth. This evidence concerns the gene PPARG and prostate carcinoma.